000 | 01831 a2200553 4500 | ||
---|---|---|---|
005 | 20250514053205.0 | ||
264 | 0 | _c20030103 | |
008 | 200301s 0 0 eng d | ||
022 | _a0035-9203 | ||
024 | 7 |
_a10.1016/s0035-9203(02)90426-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHeckendorn, F | |
245 | 0 | 0 |
_aSpecies-specific field testing of Entamoeba spp. in an area of high endemicity. _h[electronic resource] |
260 |
_bTransactions of the Royal Society of Tropical Medicine and Hygiene _c |
||
300 |
_a521-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnthelmintics _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCote d'Ivoire _xepidemiology |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aEntamoeba |
650 | 0 | 4 | _aEntamoeba histolytica |
650 | 0 | 4 |
_aEntamoebiasis _xdrug therapy |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGiardiasis _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetronidazole _xtherapeutic use |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 |
_aPraziquantel _xtherapeutic use |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 |
_aSchistosomiasis mansoni _xdrug therapy |
650 | 0 | 4 | _aSpecies Specificity |
700 | 1 | _aN'Goran, E K | |
700 | 1 | _aFelger, I | |
700 | 1 | _aVounatsou, P | |
700 | 1 | _aYapi, A | |
700 | 1 | _aOettli, A | |
700 | 1 | _aMarti, H P | |
700 | 1 | _aDobler, M | |
700 | 1 | _aTraoré, M | |
700 | 1 | _aLohourignon, K L | |
700 | 1 | _aLengeler, C | |
773 | 0 |
_tTransactions of the Royal Society of Tropical Medicine and Hygiene _gvol. 96 _gno. 5 _gp. 521-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0035-9203(02)90426-8 _zAvailable from publisher's website |
999 |
_c12279377 _d12279377 |